Ribosomal protein L39 pseudogene 16 (RPL39P16)

**RPL39P16 (Ribosomal protein L39 pseudogene 16)** is a human pseudogene related to the ribosomal protein L39 family[5][6]. Pseudogenes are DNA sequences similar to normal genes but are non-functional; they are generally not transcribed into functional protein products and do not have known biological activity[5]. RPL39P16 is not considered a protein-coding gene, therapeutic target, or receptor, and there is no evidence that it has a role in any cellular or disease processes. **Context and supporting details:** - RPL39P16 is one of many **processed pseudogenes** of the ribosomal protein L39 gene (RPL39), which codes for a structural protein of the ribosome large subunit (60S) in humans[2][5]. - It is listed with several aliases, including RPL39_5_258, across genetic and reagent registries, but **no biological function, therapeutic relevance, or disease connection** is reported in available scientific sources[5][6]. - There is **no evidence for transcription, translation, or drug interactions** associated with RPL39P16[5]. - Multiple similar pseudogenes exist for ribosomal proteins, and these sequences are **not functional genes or valid drug targets**[2][5]. - The presence of “pseudogene” in the name and absence from curated lists of therapeutic targets indicates this entry is **not a molecular target** for drugs or research interventions and should be flagged as such[2][5]. **Summary:** RPL39P16 is a **non-functional pseudogene**, not a protein-coding gene, and is not considered a therapeutic target. There are no known functions, disease associations, or drug interactions, so if your intent was to collect information on a genuine molecular target, this entry is incorrect and should be excluded from such lists[2][5][6].

Other names

RPL39_5_258RPL39P16